Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CVRx (CVRX) Net Income towards Common Stockholders (2020 - 2026)

CVRx has reported Net Income towards Common Stockholders over the past 7 years, most recently at -$13.1 million for Q1 2026.

  • For Q1 2026, Net Income towards Common Stockholders rose 4.69% year-over-year to -$13.1 million; the TTM value through Mar 2026 reached -$52.7 million, down 2.2%, while the annual FY2025 figure was -$53.3 million, 11.07% up from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 was -$13.1 million at CVRx, down from -$12.0 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at -$9.0 million in Q3 2023 and troughed at -$22.2 million in Q1 2024.
  • A 5-year average of -$12.3 million and a median of -$11.7 million in 2023 define the central range for Net Income towards Common Stockholders.
  • Biggest five-year swings in Net Income towards Common Stockholders: crashed 95.06% in 2024 and later soared 37.95% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at -$10.5 million in 2022, then increased by 14.43% to -$9.0 million in 2023, then fell by 18.13% to -$10.7 million in 2024, then decreased by 12.21% to -$12.0 million in 2025, then dropped by 9.77% to -$13.1 million in 2026.
  • Business Quant data shows Net Income towards Common Stockholders for CVRX at -$13.1 million in Q1 2026, -$12.0 million in Q4 2025, and -$12.9 million in Q3 2025.